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Although research studies using electrohysterography on women without tocolytic therapy have shown 16 
its potential for preterm birth diagnosis, tocolytics are usually administered in emergency rooms at the 17 
first sign of threatened preterm labor (TPL). Information on the uterine response during tocolytic 18 
treatment could prove useful for the development of tools able to predict true preterm deliveries under 19 
normal clinical conditions. The aim of this study was thus to analyze the effects of Atosiban on 20 
Electrohysterogram (EHG) parameters and to compare its effects on women who delivered preterm 21 
(WDP) and at term (WDT). Electrohysterograms recorded in different Atosiban therapy stages (before, 22 
during and after drug administration) on 40 WDT and 27 WDP were analyzed by computing linear, 23 
and non-linear EHG parameters. Results reveal that Atosiban does not greatly affect the EHG signal 24 
amplitude, but does modify its spectral content and reduces the energy associated with the fast wave 25 
high component in both WDP and WDT, with a faster response in the latter. EHG signal complexity 26 
remained constant in WDT, while it increased in WDP until it reached similar values to WDT during 27 
Atosiban treatment. The spectral and complexity parameters were able to separate (p <0.05) WDT and 28 
WDP prior to and during tocolytic treatment and before and after treatment, respectively. The results 29 
pave the way for developing better and more reliable medical decision support systems based on EHG 30 
for preterm delivery prediction in TPL women in clinical scenarios. 31 
Keywords: Electrohysterogram, Atosiban, excitability, complexity, preterm labor.  32 
3 
 
1. INTRODUCTION 33 
1.1. Preterm labor and tocolytic treatment 34 
The World Health Organization defines preterm labor (PL) as all births that take place before the end 35 
of the 37th week, or 259 days, of gestation (1). In developed countries the preterm delivery rate is 36 
around 10% of total births (2,3) and has risen in most industrialized countries (3). 75% of perinatal 37 
mortality is associated with preterm labor, while the survivors have an increased risk of cardiovascular, 38 
respiratory, and neurodevelopmental complications and will require monitoring by specialists in the 39 
first years of their lives (3,4). All the complications associated with PL entail higher social and 40 
economic costs in terms of intensive care and long-term monitoring than term births. Studies carried 41 
out in the USA have shown that preterm births can cost up to five times more than term births (4). 42 
While the methods currently used to diagnose PL in clinical practice, such as Bishop Score, fetal 43 
fibronectin, cervical length and tocodynamometry are inaccurate and/or subjective (5–7), early 44 
detection of spontaneous PL is vital in order to prevent or mitigate the negative consequences of 45 
preterm deliveries on newly born infants. Antenatal corticosteroids, which have been shown to reduce 46 
neonatal mortality and the multiple complications associated with preterm deliveries, are the best 47 
option in such cases (8). However antenatal corticosteroids require at least 48 hours to take effect and 48 
lasts up to 7 days, so that one of the aims of tocolytic therapy is to maintain the pregnancy as long as 49 
the effects of antenatal corticosteroids last. These drugs also impair microorganisms from the vagina 50 
entering the amniotic cavity and help to reduce the risk of infection (9). 51 
A variety of tocolytic drugs with different action mechanisms are now used in clinical practice to 52 
prevent PL, such as betamimetics, calcium channel blockers, oxytocin receptors, among others (9). 53 
During pregnancy uterine activity is mainly regulated by the balance between progesterone and 54 
oxytocin (10). Specifically, oxytocin molecules have proven to be a key factor in the progression or 55 
induction of labor, being capable of increasing uterine activity in humans (10,11). In this sense, 56 
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Atosiban is a synthetic peptide (desamino-oxytocin analog) that has been shown to be a competitive 57 
oxytocin and vasopressin antagonist (11,12). Atosiban, widely used in Europe (9,12), blocks the 58 
oxytocin receptors of myometrial cells, inhibiting the release of Ca2+ ions into the cytoplasm (9). These 59 
+ ions play an important role in smooth-muscle cell contractions, as the depolarization phase is mainly 60 
due to inward currents of Ca2+ and Na+ ions (10,13,14). Since Atosiban blocks the oxytocin receptors 61 
impairing the entrance of Ca2+ ions, it reduces cell excitability, as reported in some in vitro studies on 62 
human myometrial cells (12). ). A reduced excitability involves that myometrial cells will contract less 63 
frequently, in lower number and less synchronized (12,15,16). Other studies on humans have also 64 
reported reduced uterine activity associated with Atosiban (12,16). 65 
1.2. Electrohysterogram in preterm labor diagnosis 66 
Electrohysterography is a noninvasive tool to characterize the electrophysiological state of the uterus 67 
and provide information on labor onset (6,17,18). Uterine myoelectrical activity (electrohysterogram, 68 
EHG) is recorded through electrodes on the maternal abdomen (19,20). These recordings can 69 
differentiate between the basal tone, associated with the resting state of the uterus, and the EHG-bursts, 70 
which represent the electrical activity associated with the contractions of myometrial cells. EHG-bursts 71 
have two main components: the fast wave low (FWL) in the [0.13 - 0.26] Hz range associated with 72 
EHG propagation, and the fast wave high (FWH), which contains the high frequency content of the 73 
EHG signal [0.36 – 0.88] Hz, and has been said to be directly related to myometrial cell excitability 74 
(19,21). 75 
Most authors make use of parameters extracted from the EHG for predicting PL, with good 76 
classification results, including values of: 0.94 (22), 0.98 (23) and 0.96 (24) for the area under the ROC 77 
curves, among others. However, despite their reputed high accuracy, EHG recording protocols and 78 
analysis tools are still restricted to the research field (25,26). There are several reasons for this: 79 
clinicians are not familiar with the technique and its interpretation, there is no standard regarding 80 
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electrode position and configuration, and the recording protocols and devices need to be simplified 81 
and made more compact. Another relevant factor is that EHG recordings have always been carried out 82 
on women during regular check-ups under physiological conditions (20,26), whilst in clinical practice 83 
tocolytic therapies are usually administered at the first signs of TPL. 84 
1.3. Electrohysterogram during tocolytic treatment 85 
Tocolytic drugs are indicated to impair uterine myoelectrical activity. Some authors have found fewer 86 
uterine contraction when measured by ultrasound (27), while others have reported a reduction of 87 
between 57 - 65 % in uterine activity estimated by external tocodynamometry (11). However, 88 
considering only the number of contractions per minute is not enough to evaluate the uterine response 89 
to tocolytics or for predicting PL. Some studies describe how different tocolytic agents can affect EHG 90 
recordings and analyses (15,16,28), but only analyzed the patients twice: prior to tocolytic drug 91 
administration and immediately after the treatment. In addition, no distinction was made between the 92 
truly preterm mothers (WDP) and those who finally delivered at term (WDT), thus masking possible 93 
differences in their tocolytic response. These limitations are vitally important since tocolytic treatments 94 
usually take around 48h. This time lapse is relevant, since detecting false alarms in the early stages of 95 
tocolytic administration could save health systems huge amounts of money by avoiding unnecessary 96 
hospitalizations and would also improve attention to the truly preterm mothers. Information on the 97 
response of WDT and WDP groups to tocolytic drugs could thus be a key factor in developing tools 98 
able to predict true preterm deliveries in clinical practice. 99 
In this context, the aim of this work was to characterize and compare the effects of Atosiban on EHG 100 
signals recorded in mothers with TPL who truly delivered preterm and those who finally delivered at 101 
term. 102 
2. MATERIALS & METHODS 103 
2.1. Subjects and EHG recordings 104 
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A total of 146 EHG 30 – 200 min recordings from 86 pregnant women admitted to the “Hospital 105 
Universitario y Politécnico la Fe” (Valencia, Spain) showing symptoms of TPL were included in this 106 
study, which was approved by the Hospital Institutional Review Board and adhered to the Declaration 107 
of Helsinki. All the participants were informed of the characteristics of the study and the recording 108 
protocol prior to giving their written informed consent. All the subjects presented preterm labor 109 
symptoms such as cervical effacement or regular uterine dynamics on admission. Gestational ages 110 
ranged between 25 – 36 weeks. Recordings were made under normal clinical conditions i.e. most of 111 
the subjects were under the effect of tocolytic therapies. Few of the subjects could be recorded prior to 112 
Atosiban administration since tocolytic therapy is mostly administered in the emergency room and 113 
maternal-fetal welfare is given priority. Some of the subjects had been remitted from other health 114 
centers in which they already received the first dose of Atosiban. 115 
Atosiban was administered by means of an intravenous bolus injection (6.75 mg) for 1 min, followed 116 
by 18 mg/h for 3 h and a final maintenance dosage of 6 mg/h for 45 h. The patients were grouped into 117 
five different stages according to the time lapse between the EHG recording and the start of Atosiban 118 
therapy: S0 (before therapy, <0 h), S1 (1 – 24 h), S2 (24 – 48 h), S3 (48 – 72 h) and S4 (>72 h). 119 
All the patients were followed up until delivery. Excluding criteria were: non spontaneous labor 120 
initiation (21/146), preterm membrane rupture (10/146) and multiple gestations (5/146). 110 of 146 121 
EHG recordings from 67 patients were included in the EHG analysis. In all cases Atosiban achieved 122 
short-term success, i.e. none of the patients delivered <48h after initiation of the therapy, although 123 
27/67 women delivered preterm (WDP group) and 40/67 delivered at term (WDT group). Figure 1 124 
shows the EHG recording cohorts, separating term and preterm deliveries in each therapy stage. 125 
Further obstetrical information on the subjects is shown in Table 1, including maternal age, gestational 126 
age, previous gestations and cervical length. 127 
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The abdominal skin was carefully prepared to reduce skin-electrode impedance prior to recording by 128 
Nuprep abrasive paste. Two disposable monopolar Ag/AgCl electrodes (3M red dot 2560) were 129 
symmetrically positioned with respect to the median axis over the umbilicus, with a distance of 8 cm 130 
between electrodes (See Figure 2). Two disposable electrodes were also placed on the subjects’ hips 131 
as reference and ground electrodes. This configuration was chosen to simplify the acquisition protocol 132 
and to allow simultaneous clinical recordings by other devices, such as TOCO or ultrasound monitor, 133 
as shown in Figure 2. A custom-made wireless recording module was used to acquire the bioelectrical 134 
signals, providing a 2059 V/V gain in the 0.1 to 150 Hz band and digitalizing the monopolar signals 135 
by a 24 bit ADC at 500 Hz (29). 136 
2.2. EHG signals analysis 137 
Since most of the EHG spectral content distributes between 0.1 to 4 Hz range (18) monopolar EHG 138 
signals (M1 and M2, see Figure 2) were digitally filtered in that range (zero-phase 5th order Butterworth 139 
band-pass filter), and then downsampled at 20 Hz so as to maintain the trade-off between temporal 140 
resolution and computational cost. Once the monopolar signals were conditioned, a bipolar signal was 141 
calculated as their difference to reduce common-mode interferences and increase signal quality (30).  142 
In this work whole EHG window analysis was used to characterize the EHG signals rather than EHG 143 
burst analysis because - it greatly simplifies the segmentation process; - previous results reveal that 144 
this kind of analysis outperforms EHG-burst one in providing information about labor horizon (31); 145 
this kind of analysis would be easier to implement on real time systems that provide bedside results. 146 
The EHG segments were divided into 120 s windows with a 50% overlap. This selection was based on 147 
a previous work that compared different window length (1 min, 2 min, 5 min and 10 min) to 148 
differentiate EHG signal of patients who finally delivered in less than 7 days from those who delivered 149 
in more, attempting to maintain a trade-off between computational cost and the amount of discarded 150 
data (31).  151 
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The EHG parameters were calculated in each window. The median value of all the analysis windows 152 
of the EHG recordings was then calculated to obtain a single representative value of each parameter 153 
and recording. Figure 3 contains an explanatory diagram of the entire analysis. 154 
A set of EHG parameters was selected to determine the effects of Atosiban on uterine myoelectrical 155 
activity in the WDT and WDP groups, including temporal, spectral and non-linear features: peak to 156 
peak amplitude (18), H/L ratio and Lempel-Ziv complexity (32). Peak to peak amplitude, directly 157 
related to the intensity of uterine contractions, is one the most widely used parameters for EHG 158 
characterization (18). As the spectral parameters can also be used to evaluate cell excitability (21), a 159 
high to low energy ratio parameter (H/L Ratio) was calculated to consider this aspect. The H/L Ratio 160 
represents the relation between the FWH energy computed in (0.34-1 Hz) with respect to the FWL 161 
energy computed in (0.2-0.34 Hz) so as to minimize the influence of cardiac interference and baseline 162 
fluctuation and is defined as: 163 
𝐻
𝐿⁄  𝑅𝑎𝑡𝑖𝑜 =
∑ 𝑃𝑆𝐷10.34
∑ 𝑃𝑆𝐷0.340.2
 (1) 164 
Non-linear parameters have been widely used in EHG studies to characterize the electrophysiological 165 
state of the uterus and obtain information on the labor time horizon (33). In a previous study, various 166 
non-linear parameters have been used to characterize EHG signals recorded from women with 167 
threatened preterm labor (under tocolytic treatment): sample entropy, spectral entropy, Time 168 
reversibility and Lempel-Ziv complexity (31). We found that Lempel-Ziv was the most reliable 169 
parameter for discriminating women who delivered <7 days from the others (31). So as to compute the 170 
Lempel-Ziv complexity, the signal is firstly converted into a binary sequence, by using the median 171 
value as threshold, given its robustness to outlier values (32). The resulting sequence is scanned from 172 
left to right, increasing the complexity counter by one unit every time a new subsequence is 173 
encountered. Higher Lempel-Ziv values involve more complex patterns close to randomness, and in 174 
contrast low values are related with more organized or less complex signals (32,34). In this work, 175 
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Lempel-Ziv complexity was computed in the whole EHG bandwidth (0.1- 4 Hz) since it has been 176 
proven in a previous study (31) to better discriminate patients who finally delivery at term from the 177 
preterm ones when compared with other analyzed bandwidths: 0.34-4 Hz, 0.34-1 Hz. 178 
A two-sided comparison by the Wilcoxon statistical test (α = 0.05) was performed to assess the 179 
differences between the EHG parameters. The WDT and WDP recordings were first compared in each 180 
Atosiban administration stage (S0, S1, S2, S3 and S4), and then those from all the Atosiban stages of 181 
the same group were also compared. No significant differences were found for any obstetrical feature 182 
when those included in Table 1 were compared in the same way. 183 
3. RESULTS 184 
Figure 4 shows the evolution of the EHG parameters during early Atosiban administration, 185 
corresponding to the transition from stage S0 to stage S1, for a preterm and term delivery. It can be 186 
seen that the EHG amplitude is always higher for the former than the latter, there is no conclusive 187 
amplitude trend for either case and in both cases the H/L Ratio decreased during Atosiban 188 
administration. WDT had a steeper H/L Ratio drop response in the first 15 minutes, followed by a 189 
monotonical decrease and a smaller slope (similar to that of WDT) during the 18 mg/h Atosiban 190 
treatment. WDP had higher H/L ratio values than WDT during the entire recording and also higher 191 
initial Lempel-Ziv complexity values, this latter indicating a less coordinated and organized EHG 192 
signal. WDT did not seem to be greatly affected by the tocolytic therapy in this case, although WDP 193 
showed a remarkable increase in the Lempel-Ziv index during the first 15-20 minutes of Atosiban 194 
administration, after which the values and trend became similar to those of WDT. 195 
Figure 5 shows a longitudinal study of three EHG recordings with their associated power spectrum 196 
densities (PSD) and Lempel-Ziv values of two single patients (WDP & WDT) at different stages of 197 
Atosiban administration. In both cases the signal´s amplitude has no large variations between stages 198 
S0, S2 and S4 stages. High frequency components (0.34 - 1 Hz) can be appreciated in the signal PSDs 199 
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of stage S0 recordings i.e. before Atosiban administration in both WDP and WDT. In S2 there are 200 
fewer high frequency components. Note that the recording of the WDP was performed 42 h after the 201 
tocolytic treatment for the preterm labor patient. That is, in this particular case the recording was 202 
performed close to stage S3 which may explain the visually significant drop of the high frequency 203 
spectral content. In stage S4, i.e. recordings taken more than 72h after Atosiban administration, when 204 
the effects of the drug are weaker, the high frequency components can be seen again. WDP Lempel-205 
Ziv complexity has a low value in S0, which is associated with the more organized and coordinated 206 
signals close to labor. After administering Atosiban the Lempel-Ziv complexity greatly increases its 207 
value in S2. In S4 it still has a similar complexity level. WDT signal complexity already shows a higher 208 
initial complexity value during stage S0 and so is not greatly affected by the tocolytic. 209 
Figure 6 contains the violin-plots and median values (squares) of each EHG parameter in the different 210 
Atosiban stages for both term and preterm groups. In contrast to Figures 4 and 5, which give the 211 
Atosiban response of individual patients, Figure 6 includes information on the global response of all 212 
the WDT and WDP to Atosiban during the different stages. Significant differences between the term 213 
and preterm groups in the same stage are indicated in the tables above the violins, while the significant 214 
differences between the stages for the same WDP or WDT group are given above and below the 215 
violins, respectively. Both term and preterm groups show a similar signal amplitude evolution. This 216 
dropped slightly in S1, rapidly increased in S2 and S3 and fell again after 72h of drug administration 217 
(S4). No significant differences were found between the term vs preterm groups in any drug stage. 218 
The median values of the H/L Ratio for the preterm group were higher than those of the term group in 219 
all the stages and were statistically significant for S0, S1 and S2. These differences are noteworthy 220 
since they could be used to differentiate WDT and WDP before and during Atosiban treatment. The 221 
median values of the H/L ratio also show different trends. The WDT H/L ratio suddenly fell to its 222 
minimum value in S1 (first 24h of tocolytic therapy) while the median WDP value was even higher in 223 
S1 than S0 and fell to its minimum value in stage S3. This response can also be appreciated in the 224 
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significant differences among the stages (p <0.05). S0 was significantly different to S1 and S2 for 225 
WDT (rapid response) but not for WDP. In this latter group, the sustained significant differences were 226 
‘delayed’ in S1 vs S2, S3 and S4, suggesting WDT had a faster response to the tocolytic drug than 227 
WDP. This was also seen in the individual case shown in Figure 4, where the WDP took longer to 228 
reduce the H/L Ratio values than the WDT. After 72h of drug administration the H/L ratio increased 229 
in both groups, indicating a similar total duration of the effects of Atosiban. 230 
EHG signal complexity showed significantly higher values for WDT than WDP in S0. The higher 231 
EHG signal complexity or signal disorder may suggest that the uterine status of these patients indicates 232 
a longer time to delivery. This result agrees with the individual response shown in Figures 4 and 5, 233 
where the WDP (close to labor) showed lower Lempel-Ziv values than WDT before Atosiban 234 
administration. Again, this could be of great interest to discriminate between term and preterm 235 
deliveries. The Lempel-Ziv also showed different trends in the two groups studied. The WDT median 236 
Lempel-Ziv values were not greatly affected during drug administration, presenting no significant 237 
differences between any stages. The WDP Lempel-Ziv increased significantly in the first 24h after 238 
Atosiban administration. Significant differences with S0 values were maintained until 72h after 239 
administration. Similar values were obtained after this increase (S1-S3) for both WDP and WDT, 240 
probably associated with the successful avoidance of imminent delivery. After 72h of therapy the WDP 241 
Lempel-Ziv parameter fell significantly (S4 in comparison with S3, S2 and S1) and reached a similar 242 
median value to S0, seeming to point to the end of the drug’s effect on the preterm labor cases. 243 
4. DISCUSSION 244 
Obstetrics urgently needs to be able to predict whether women with TPL in normal clinical conditions 245 
will have true preterm deliveries. Most EHG studies on predicting preterm labor are carried out during 246 
regular check-ups and have not considered the influence of tocolytic therapies. Precise information on 247 
the effects of these therapies on electrohysterographic signals could lead to more reliable labor 248 
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prediction systems, improve maternal-fetal wellbeing and avoid unnecessary hospitalizations. In the 249 
present study temporal, spectral and non-linear parameters were used to evaluate the effect of Atosiban 250 
on uterine myoelectrical activity on WDT and WDP groups, unlike previous studies that analyzed 251 
patients only before and after tocolytic drug administration (≈ 48h) (9,16,28). This study included a 252 
detailed analysis of the effect of the tocolytic agent in different stages of the treatment, separating term 253 
from preterm patients to obtain information on the physiological response to Atosiban, which could 254 
permit a more accurate interpretation of the EHG signal in a clinical context. It also paves the path for 255 
the development of specific expert systems based on EHG signals that consider the Atosiban stage that 256 
would permit more reliable preterm labor prediction.  257 
Similar EHG signal amplitude, trends and values were obtained for WDP and WDT during Atosiban 258 
treatment. Amplitude stayed almost constant during the first 24h of therapy, increased between 24 and 259 
72h and then decreased for both term and preterm groups. Kandil et al (15) recorded EHG in the same 260 
pregnant women before and after treatment with hexoprenaline sulphate and found reduced EHG 261 
signal amplitude, burst duration and frequency of occurrence in women in which tocolysis was 262 
effective in prolonging pregnancy by at least 48 h. The women who failed to respond to tocolysis (labor 263 
in less than 48h) had neither reduced EHG amplitude nor burst duration after the treatment. In the 264 
present work tocolysis was effective in all the women studied, which according to Kandil’s results 265 
would mean reduced signal amplitude during therapy. As the present work was a cross-sectional study 266 
and there was wide variation in the amplitude values, the significance of this parameter is limited. 267 
Amplitude strongly depends on the recording conditions and individual factors such as skin impedance 268 
and the thickness of the fat layer (35,36), so that it is reasonable to expect masked trends and 269 
overlapping distributions when grouping different subjects. In this sense, some non-invasive measures, 270 
such as the BMI, may provide indirect information about fat layer that could be used for amplitude 271 
normalization. However, BMI could be inaccurate or non-representative of the fat content in pregnant 272 
women because the weight is greatly influenced by the fetus development. Therefore, EHG amplitude 273 
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values are not usually normalized. Instead of using amplitude normalization techniques, most authors 274 
prefer to use other features for characterizing the EHG signal, such as spectral or non-linear parameters, 275 
which have proven to be less sensitive to bioelectrical recording amplitude. 276 
In the spectral content distribution of uterine myoelectrical signals a marked trend towards lower 277 
frequencies was found during Atosiban therapy. This is probably due to the fact that Atosiban actively 278 
reduces cell excitability by blocking oxytocin receptors (11,12). This blocking turns into a decrease of 279 
the high frequency content (FWH energy) and thus a drop of the H/L Ratio. These results are in 280 
agreement with the reduced EHG peak frequency reported by Vinken et al in women treated with 281 
Nifedipine. They found lower PSD peak frequency values for signals recorded within 15 min after 282 
administration of Nifedipine than those obtained before the drug treatment (28). They also reported 283 
higher peak frequency values in patients recorded within 24h after starting Nifedipine (S1 in the present 284 
study) against those recorded 24h after finishing the tocolytic treatment (S4 here). In the present work, 285 
EHG was recorded in a wider range of treatment stages and this shift towards lower frequency content 286 
was seen to be ‘delayed’ in the WDP group. This delay in the reduction of high frequency EHG 287 
components in preterm women could be directly related to the number of oxytocin receptors expressed 288 
by myometrial cells. It is reasonable to expect more receptors in WDP than WDT myometrial cells, 289 
since labor is closer (see time to delivery in Table 1) (10,12), which means that Atosiban takes longer 290 
to block all the oxytocin receptors and inhibit cell excitation. Should this different trend be confirmed 291 
in a larger database, it would support the potential diagnostic value of monitoring this EHG parameter 292 
during the first few hours of tocolytic treatment. 293 
Vinken et al (28) also report a higher average PSD peak EHG frequency recorded 24h after treatment  294 
in patients who delivered < 7 days than for >7 days from Nifedipine therapy initiation. This group 295 
classification could not be performed in the present work due to a database imbalance. Nevertheless, 296 
the higher median H/L Ratio values during all stages of the WDP group (median TTD 10.5 days) 297 
compared to WDT group (median TTD 49 days) are in agreement with those reported in (28). It should 298 
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also be noted that these differences are reduced after tocolytic therapy (S3 & S4), so that the stage in 299 
which the recording takes place could be of great importance for decision support systems when 300 
predicting preterm labor. 301 
As far as we know, there are no previous studies which evaluate the effect of Atosiban on the EHG by 302 
non-linear parameters. In this work, the regularity of the uterine myoelectrical signal was assessed by 303 
computing the Lempel-Ziv parameter. High Lempel-Ziv values involve more complex patterns closer 304 
to randomness, and by contrast, low values are related with more organized signals (34,37). Our 305 
hypothesis is that EHG signal complexity (LZ value) is associated to the uterine cells’ connectivity, 306 
which is required to generate synchronized myoelectric activity to expel the fetus during labor. The 307 
more synchronized and propagated action potentials (high connectivity between muscular cells) the 308 
more organized EHG signals (26,32,38). In this sense, prior to Atosiban administration, the WDP 309 
signal complexity was significantly lower than that of WDT, indicating that Lempel-Ziv could be 310 
useful in predicting preterm labor in TPL patients not administered Atosiban. Our results showed that 311 
no significant changes in LZ parameter were observed in WDT group after drug administration. 312 
Women in this group are far from delivery and connectivity between uterine cells is poor; therefore 313 
drug administration does not alter this characteristic nor the associated EHG feature (LZ). Whereas in 314 
WDP group, lower LZ values before Atosiban administration than in WDT reflect enhanced uterine 315 
cells interconnection that could lead to labor in a shorter period of time. During the tocolytic treatment, 316 
the amount of propagated action potentials is decreased due to the inhibitory effect of contractile 317 
activity of Atosiban, given rise to a more random EHG signal and higher LZ values. This occurs shortly 318 
after the first bolus of high concentration of Atosiban (S1), suggesting a faster effect in comparison to 319 
what happened with cell excitability and H/L ratio. LZ parameter may not be useful in discriminating 320 
between term and preterm deliveries when recordings are made during Atosiban therapy. Twenty-four 321 
hours after the end of therapy (72h after initiation), the propagated action potentials were reestablished 322 
in preterm labor group, that is, the failure of Atosiban in the longer term could be inferred from the 323 
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significantly lower Lempel-Ziv values in the WDP group at this stage. This contrasts with the H/L 324 
Ratio, which was able to separate WDT from WDP during the early stages of drug administration, but 325 
not in the final stages after the tocolytic treatment. 326 
Finally, it can be said that no significant differences were found between the groups or stages in any 327 
of the obstetrical features shown in Table 1 (except those related to time to delivery). The different 328 
groups present homogeneous composition from an obstetrical point of view and thus results of EHG 329 
features are not biased due to differences in the gestational age at the moment of the recording or any 330 
other obstetrical feature. Differences in EHG parameters are then expected to be associated to uterine 331 
electrophysiological condition and its response to Atosiban. 332 
Despite the reduced size of our actual database, we tested different classifiers based on logistic 333 
regression in order to distinguish between WDT and WDP in each of the different Atosiban stages, 334 
and a global classifier which included all the recordings of the database without taking into account in 335 
which Atosiban stage the EHG recordings were performed. Preliminary results (not shown) point that 336 
best classification performance is obtained for recordings prior to Atosiban administration, followed 337 
by stage 1. The worst performance was obtained with the global classifier which does not take into 338 
account the Atosiban stage. These results highlight the need to consider the tocolytic treatment stage 339 
for contextualizing the EHG signal and features in order to develop reliable medical decision support 340 
systems for predicting preterm deliveries in women with threatened preterm labor. 341 
We are actively working to increase the number of TPL patients in different tocolytic stages and 342 
extrapolate the conclusions obtained to a global population to further the development of reliable PL 343 
prediction tools in normal clinical scenarios.  344 
5. CONCLUSIONS 345 
This paper describes an evaluation of the effects of administering Atosiban on uterine myoelectrical 346 
activity in women with TPL, distinguishing between term and preterm deliveries. 347 
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Reduced spectral content was found in the fast wave bandwidth in all the women during Atosiban 348 
therapy. This therapy took longer to reduce cell excitability in women who delivered preterm, since 349 
myometrial cells express more oxytocin receptors in these patients than in those further away from 350 
labor. The women who delivered preterm also showed lower signal complexity than those at term 351 
before Atosiban and 24h after the end of the therapy. Atosiban was also found to equalize signal 352 
complexity in all the women during tocolytic therapy. 353 
The spectral content and the signal complexity level were revealed as potential indicators for separating 354 
truly preterm from term deliveries. The different responses to Atosiban of the WDT and WDP groups 355 
reported here indicate that the stage in which the recording takes place may have a strong influence on 356 
the development and discrimination capability of PL predictive tools, as the perspectives are 357 
potentially better in recordings prior to the administration of tocolytics. However, this is uncommon 358 
in clinical practice. During the first 48h of treatment, spectral parameters could still be potentially 359 
useful to separate term and preterm deliveries. Complexity parameters may not be quite so useful in 360 
these tocolytic treatment stages; conversely, 72h after therapy initiation, the complexity parameters 361 
could work better than spectral ones to discriminate WDP from WDT. In this sense, the study revealed 362 
that WDP showed lower signal complexity than WDT before Atosiban (S0) and 72h after the initiation 363 
of Atosiban administration (S4). 364 
When longitudinal measurements can be performed on the same patient, special attention must be paid 365 
to this time lapse in order to reduce hospital admissions and avoid repetition of pharmacological doses.  366 
In-depth knowledge of how the recorded EHG is affected by tocolytic therapies will pave the way for 367 
improved and more reliable medical decision support systems for predicting preterm deliveries in 368 
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Fig. 1: EHG recording cohort in the different stages. 504 
 505 




Fig. 3: Diagram of the whole EHG window analysis methodology. The length of each window was 510 
fixed to 120 s with a 50% overlap. 511 
  512 
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Fig. 4: Evolution of EHG parameters during first hours of Atosiban administration for two different 513 
TPL patients, one preterm (yellow) and one term (purple). 514 
 515 
Legend: The beginning of Atosiban treatment in the first minutes of the recording. LZ-Bin correspond 516 




Fig. 5: EHG recordings carried from two patients, one preterm and one term, their associated PSDs 519 
and Lempel-Ziv complexity values in three different stages: S0, S2 and S4 (The elapsed time between 520 
Atosiban administration and the EHG recording is indicated by the value in brackets under each stage). 521 
Note that PSDs and Lempel-Ziv values are associated to the whole EHG recordings. Shaded region of 522 
the PSDs is the Fast Wave High (FWH) bandwidth. 523 
 524 
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Fig.6: Median value of EHG parameters in the different Atosiban stages, for term (purple) and preterm 526 
(yellow) patients. The different stages according to the time lapse between the EHG recording and the 527 
initiation of Atosiban therapy are: S0 (before, <0 h), S1 (>0 – 24h), S2 (24 – 48h), S3 (48 -72h) and 528 
S4 (>72 h). 529 
 530 
Legend: Significant differences between term and preterm groups for all Atosiban administration 531 
stages are indicated in the tables (●), and the differences between stages for the same group: WDP or 532 
WDT is shown above and below the violins, respectively (*). LZ-Bin correspond to the Lempel-Ziv 533 
complexity computed by converting the signal into a binary sequence 534 
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Table 1. Obstetrical features of the women in the different stages: Median (Interquartile range). 536 
 Preterm 
 S0 S1 S2 S3 S4 
Maternal Age (years) 29 (7.0) 32 (14.2) 31 (8.0) 34 (13.5) 34 (10.5) 
Gestations 1 (1.00) 2 (1.75) 1 (2.00) 1 (1.50) 1 (0.50) 
Cervical Length (mm) 11 (18.0) 13 (7.5) 15.5 (10.5) 16 (11.0) 18 (24.5) 
Gestational age at 
Delivery (weeks) 
34.0 (1) 34.0 (3.5) 33.0 (1.5) 33 (2.5) 34 (2) 
Time to Delivery 
(Days) 
12.5 (28.5) 27 (25) 13.5 (12) 12 (16) 13 (10.5) 
Gestational age at 
Recording (weeks) 
33 (3.0) 29 (4.5) 31.5 (3.5) 31 (3.2) 32 (3.0) 
 Term 
Maternal Age (years) 36 (15.0) 33 (10.0) 33 (5.0) 34 (6.0) 34 (4.7) 
Gestations 2 (1.0) 2 (2.0) 1.5 (2.0) 1.5 (2.0) 1 (0.5) 
Cervical Length* (mm) 14 (18) 20 (19) 22 (17) 27.5 (11) 23 (11) 
Gestational age at 
Delivery (weeks) 




Time to Delivery 
(Days) 
56.5 (23) 53.5 (27.5) 48 (26) 52 (33) 41 (25) 
Gestational age at 
recording (weeks) 







*In most patients Cervical Length was measured prior to the administration of Atosiban (not when 538 
EHG record was performed), since it indicates TPL. 539 
Legend: Wilcoxon statistical tests were performed on the different groups (term and preterm) in all 540 
stages (S0, S1, S2, S3 and S4) and on the different stages in each group for all obstetrical features. No 541 
significant differences were obtained for any feature during the different stages, except when 542 
comparing the time to delivery and the gestational age at the moment of the delivery between WDP 543 
and WDT. 544 
